{
    "Trade/Device Name(s)": [
        "PATHIAM Image Analysis Software for Her2/neu",
        "PATHIAM\u2122 Imaging software for Her2/neu",
        "PATHIAMTM Imaging Software for Her2/neu"
    ],
    "Submitter Information": "BioImagene, Inc.",
    "510(k) Number": "K062756",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032113"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOT"
    ],
    "Summary Letter Date": "February 12, 2007",
    "Summary Letter Received Date": "February 13, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry Reagents and Kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [
        "HER2/neu (c-erbB-2)"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded breast cancer tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Microscope with digitizing camera",
        "Digital slide scanner",
        "Computer"
    ],
    "Method(s)/Technology(ies)": [
        "Image analysis software",
        "Colorimetric pattern recognition"
    ],
    "Methodologies": [
        "Semi-quantitative measurement",
        "Object identification"
    ],
    "Submission Type(s)": [
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for PATHIAM Image Analysis Software for Her2/neu to assist semi-quantitative measurement of HER2/neu in breast cancer tissue using digital image analysis.",
    "Indications for Use Summary": "Accessory to Dako HercepTest\u00ae to aid pathologists in semi-quantitative measurement of HER2/neu in formalin-fixed, paraffin-embedded breast cancer tissue for assessment of patients considered for Herceptin\u00ae (Trastuzumab) treatment.",
    "fda_folder": "Hematology"
}